KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Debt Ratio: 2013-2025

Historic Debt Ratio for Travere Therapeutics (TVTX) over the last 5 years, with Jun 2025 value amounting to 0.12.

  • Travere Therapeutics' Debt Ratio was N/A to 0.12 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.12, marking a year-over-year change of. This contributed to the annual value of 0.12 for FY2024, which is N/A change from last year.
  • As of Q2 2025, Travere Therapeutics' Debt Ratio stood at 0.12, which was down 1.06% from 0.13 recorded in Q1 2025.
  • In the past 5 years, Travere Therapeutics' Debt Ratio registered a high of 0.14 during Q3 2024, and its lowest value of 0.01 during Q1 2023.
  • In the last 3 years, Travere Therapeutics' Debt Ratio had a median value of 0.12 in 2025 and averaged 0.09.
  • Per our database at Business Quant, Travere Therapeutics' Debt Ratio tumbled by 66.74% in 2021 and then increased by 9.23% in 2022.
  • Over the past 5 years, Travere Therapeutics' Debt Ratio (Quarterly) stood at 0.01 in 2021, then increased by 9.23% to 0.01 in 2022, then grew by 0.05% to 0.01 in 2023, then reached 0.12 in 2024, then reached 0.12 in 2025.
  • Its last three reported values are 0.12 in Q2 2025, 0.13 for Q1 2025, and 0.12 during Q4 2024.